These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9591629)

  • 1. Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades.
    Ichimura K; Schmidt EE; Miyakawa A; Goike HM; Collins VP
    Genes Chromosomes Cancer; 1998 May; 22(1):9-15. PubMed ID: 9591629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
    Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
    Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.
    Fujisawa H; Kurrer M; Reis RM; Yonekawa Y; Kleihues P; Ohgaki H
    Am J Pathol; 1999 Aug; 155(2):387-94. PubMed ID: 10433932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine mapping of a region of common deletion on chromosome arm 10p in human glioma.
    Voesten AM; Bijleveld EH; Westerveld A; Hulsebos TJ
    Genes Chromosomes Cancer; 1997 Oct; 20(2):167-72. PubMed ID: 9331567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions.
    Daido S; Takao S; Tamiya T; Ono Y; Terada K; Ito S; Ouchida M; Date I; Ohmoto T; Shimizu K
    Oncol Rep; 2004 Oct; 12(4):789-95. PubMed ID: 15375501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas.
    Jeng YM; Hsu HC
    Int J Cancer; 2003 Jul; 105(5):625-9. PubMed ID: 12740910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas.
    Chiariello E; Roz L; Albarosa R; Magnani I; Finocchiaro G
    Oncogene; 1998 Jan; 16(4):541-5. PubMed ID: 9484844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple deleted regions on the long arm of chromosome 6 in astrocytic tumours.
    Miyakawa A; Ichimura K; Schmidt EE; Varmeh-Ziaie S; Collins VP
    Br J Cancer; 2000 Feb; 82(3):543-9. PubMed ID: 10682663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN / MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas.
    Fujiwara Y; Hoon DS; Yamada T; Umeshita K; Gotoh M; Sakon M; Nishisho I; Monden M
    Jpn J Cancer Res; 2000 Mar; 91(3):287-92. PubMed ID: 10760687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas.
    Maier D; Zhang Z; Taylor E; Hamou MF; Gratzl O; Van Meir EG; Scott RJ; Merlo A
    Oncogene; 1998 Jun; 16(25):3331-5. PubMed ID: 9681833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution genome-wide allelotype analysis identifies loss of chromosome 14q as a recurrent genetic alteration in astrocytic tumours.
    Hu J; Pang JC; Tong CY; Lau B; Yin XL; Poon WS; Jiang CC; Zhou LF; Ng HK
    Br J Cancer; 2002 Jul; 87(2):218-24. PubMed ID: 12107846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and molecular analyses of 10q deletions in human gliomas.
    Steck PA; Lin H; Langford LA; Jasser SA; Koul D; Yung WK; Pershouse MA
    Genes Chromosomes Cancer; 1999 Feb; 24(2):135-43. PubMed ID: 9885980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas.
    Davies MP; Gibbs FE; Halliwell N; Joyce KA; Roebuck MM; Rossi ML; Salisbury J; Sibson DR; Tacconi L; Walker C
    Br J Cancer; 1999 Mar; 79(9-10):1542-8. PubMed ID: 10188904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.
    Tohma Y; Gratas C; Biernat W; Peraud A; Fukuda M; Yonekawa Y; Kleihues P; Ohgaki H
    J Neuropathol Exp Neurol; 1998 Jul; 57(7):684-9. PubMed ID: 9690672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity of chromosome 10p in human gliomas.
    Kimmelman AC; Ross DA; Liang BC
    Genomics; 1996 Jun; 34(2):250-4. PubMed ID: 8661060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
    Lang FF; Miller DC; Koslow M; Newcomb EW
    J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.
    Nakamura M; Ishida E; Shimada K; Kishi M; Nakase H; Sakaki T; Konishi N
    Lab Invest; 2005 Feb; 85(2):165-75. PubMed ID: 15592495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic alterations in low-grade, anaplastic astrocytomas and glioblastomas.
    Arslantas A; Artan S; Oner U; Müslümanoglu MH; Ozdemir M; Durmaz R; Arslantas D; Vural M; Cosan E; Atasoy MA
    Pathol Oncol Res; 2007; 13(1):39-46. PubMed ID: 17387387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
    Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T
    Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.